NIOSHTIC-2 Publications Search
Health hazard evaluation report: HETA-82-326-1420, Keystone Color Works, Incorporated, York, Pennsylvania.
Parrish RG; Hartle R
Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, HETA 82-326-1420, 1984 Feb; :1-15
A health hazard evaluation was conducted at Keystone Color Works, Incorporated (SIC-2865), York, Pennsylvania in September and December 1982. The evaluation was requested by the facility manager. All 13 employees were interviewed concerning their medical, occupational, and chemical exposure histories. The production process and employee work practices were observed. Urine samples were obtained for benzidine (92875) and aromatic amines analysis, biochemical and microscopic examination, and cytology. No detectable concentrations of benzidine or aromatic amines were found at the end of a normal work day. One of eight employees in the production area, who had extensive exposure to the dyes, was diagnosed as having bladder cancer. Besides the cancer case, two other employees had worked at the facility long enough to have a sufficient latency period for bladder cancer to develop following exposure to the dyes. The authors conclude that a health hazard exists due to exposure to carcinogenic dyes at the facility. Recommendations include annual screening for bladder cancer, instruction of workers in the proper handling of carcinogens, and the use and correct maintenance of approved respirators where engineering controls cannot prevent exposure.
NIOSH-Author; NIOSH-Health-Hazard-Evaluation; NIOSH-Technical-Assistance-Report; Hazards-Confirmed; Dying-industry; Region-3; Carcinogens; Bladder-cancer; Industrial-chemicals; Aromatic-amines; HETA-82-326-1420; Author Keywords: Cyclic Coal Tar Crudes, and Cyclic Intermediates, Dyes, and Organic Pigments Lakes and Toners; SOC 7664; SOC 7666; SOC 7759; DOT 550.684-014; DOT 550.685-014; DOT 551.685-082; Azo Dyes; Pigment Manufacture; Dye Manufacture; Dyes; Bladder Cancer; Urine Cytology; Cancer Screening
Field Studies; Hazard Evaluation and Technical Assistance
NTIS Accession No.
National Institute for Occupational Safety and Health
Page last reviewed: November 6, 2020
Content source: National Institute for Occupational Safety and Health Education and Information Division